High quality life science and diagnostic products
Manufacturer of products for nucleic acid extraction
SARS-CoV-2 | Respiratory diseases | Sexually transmitted diseases
NAxtra™ is a magnetic bead-based technology intended for RNA and DNA extraction from human nasopharyngeal and/or oropharyngeal swab samples, saliva, urine or vaginal swab samples. The product should be used for isolation and purification of bacterial or viral nucleic acids preparing clinical samples for downstream qualitative diagnostics and analysis, such as PCR and next- generation sequencing.
Total nucleic acid extraction from whole blood
The NAxtra™ Blood total nucleic acid extraction kit is a magnetic bead-based technology developed for total nucleic acid extraction from whole blood samples. The protocol is developed for fast and easy isolation of high integrity nucleic acids and the extraction protocol may be run by manual procedures or implemented on any open automation system.
Fast and easy isolation of high-quality DNA and RNA
The NAxtra™ Cells total nucleic acid extraction kit is a reliable solution for researchers looking to extract high-quality RNA and DNA from various cells types including mammalian primary cells, cell lines and bacteria. The kit is based on magnetic beads and provides efficient and easy extraction of high integrity nucleic acids, allowing for accurate and sensitive downstream analyses such as PCR or next-generation sequencing.
High quality products
Developed by our experienced
Secure and robust
Protocols for manual and open automation systems (e.g. King Fisher Duo/Flex, Tecan Fluent 1080, Biomek i7 and Hamilton Microlab STAR).
Fast extraction of nucleic acid using automated liquid handing robots (<15 min).
Highly attractive pricing.
Lybe Scientific is based on patent pending technology originating from strong research groups within molecular medicine, nanotechnology and chemical engineering at The Norwegian University of Science and Technology (NTNU) located in Trondheim, Norway.
We have established an ISO13485 Quality Management System and our products for diagnostic use will be CE IVD-marked in compliance with The In Vitro Medical Devices Regulation (EU) 2017/746 (IVDR). Our vision is to develop cost effective solutions for a wide range of life science and clinical diagnostic purposes.
Quality policy: Company develops, manufactures and sells In Vitro Diagnostic products that meet or exceed hospital requirements for qualitative molecular diagnostic products. Research and Development runs alongside the production to continuously enhance and improve the performance of the products. Company aims to produce high quality products that can simplify and shorten sample preparation times. Products are offered at competitive price levels. Company complies with the applicable regulatory requirements and ensure that effectiveness of the Quality Management System is maintained throughout the organization.
We are open to strategic partnership and OEM supply of kits and/or beads.
Our first product NAxtra™ nucleic acid extraction kit (CE IVD) was the preferred solution for SARS-CoV-2 diagnostics in Norway with more than 10 million reaction units sold.
We have a platform technology for superior quality nanoparticle-based extraction products tailored to a wide selection of sample types and applications.
Platform Technology – nanoparticles:
Workflow using our products
Product portfolio development plan
Sample types in pipeline
Applications for use
Tonje Steigedal, PhD
Entrepreneur and deep-tech business developer within the medical technology and life science area.
Sten Even Erlandsen, MSc
Experienced engineer with extensive competence on genetic, biological and molecular technologies, next generation sequencing and biobanks.
Sirsha Bandyopadhyay, PhD
Specialist within magnetic nanoparticles and chemical engineering processes.
Professor Magnar Bjørås
Experienced scientist within genome dynamics, infectious diseases, and molecular microbiology.
Assoc Prof. Sulalit Bandyopadhyay
CTO & Board member
Specialist within magnetic nanoparticles, functional nanomaterials, chemical engineering, scaling and production process optimization.
Mårten Wigstøl, MBA
Strategic advisor, Chairman
Senior executive with extensive experience within sample preparation, financial transactions including IPO’s, private placements, M&As and company sales.